The proportion of DLL4+ tumor cells was significantly higher in TNBC with poor response to neoadjuvant therapy, while the expression level of DLL4 was decreased in TNBC with good response to neoadjuvant therapy (Fig.S15a-b). Here, DLL4 is linked to neoplasm.